Thanachart Capital PCL buy krebskrebs
Start price
27.07.20
/
50%
€0.90
Target price
04.11.21
€1.40
Performance (%)
1.11%
End price
05.11.21
€0.91
Summary
This prediction ended on 05.11.21 with a price of €0.91. The BUY prediction by krebskrebs finished with a performance of 1.11%. Dividends of €0.033 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Thanachart Capital PCL | -5.172% | -5.172% | -14.063% | 22.222% |
iShares Core DAX® | 1.080% | -2.933% | 12.885% | 14.247% |
iShares Nasdaq 100 | 0.362% | 7.015% | 36.826% | 57.151% |
iShares Nikkei 225® | -1.155% | -1.155% | 5.073% | 3.799% |
iShares S&P 500 | 0.806% | 4.388% | 30.269% | 49.772% |
Comments by krebskrebs for this prediction
In the thread Thanachart Capital PCL diskutieren
Buy mit Kursziel 1,4
In the thread Trading Thanachart Capital PCL
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten